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Abstract. We have investigated a role for myosin in 
postmitotic Potoroo tridactylis kidney (PtK2) cell 
spreading by inhibitor studies, time-lapse video micros- 
copy, and immunofluorescence. We have also deter- 
mined the spatial organization and polarity of actin fila- 
ments in postmitotic spreading cells. We show that 
butanedione monoxime (BDM), a known inhibitor of 
muscle myosin II, inhibits nonmuscle myosin II and my- 
osin V adenosine triphosphatases. BDM reversibly in- 
hibits PtK2 postmitotic cell spreading. Listeria motility 
is not affected by this drug. Electron microscopy studies 
show that some actin filaments in spreading edges are 
part of actin bundles that are also found in long, thin, 
structures that are connected to spreading edges and 
substrate (retraction fibers), and that 90% of this actin 
is oriented with barbed ends in the direction of spread- 
ing. The remaining actin in spreading edges has a more 
random orientation and spatial arrangement. Myosin II 
is associated with actin polymer in spreading cell edges, 
but not retraction fibers. Myosin II is excluded from 
lamellipodia that protrude from the cell edge at the end 
of spreading. We suggest that spreading involves myo- 
sin, possibly myosin II. 
F 
orward movement of cell edges is necessary for lo- 
comotion of a cell across a substrate and for many 
types of cell shape change. Actin filaments play a 
key role in both cell locomotion and morphogenesis. The 
behavior of actin filaments has been studied in motile cell 
types for a number of years, particularly in a  specialized 
type of cell edge called the lamellipodium (the thin band 
of actin-rich, protrusive cytoplasm found at the  edge of 
many motile cells). It is thought that lamellipodia protru- 
sion is driven at least in part by forces deriving from actin 
polymerization (Abercrombie, 1980; Cooper, 1991; Singer 
and Kupfer, 1986; Theriot and Mitchison, 1991). Protru- 
sive force in lamellipodia may be related to the force that 
propels the bacterium Listeria monocytogenes  forward in 
infected cells (Sanger et al.,  1992; Theriot and Mitchison, 
1992). Recently, however, it has been shown that forward 
movement of other types of cell edges is not driven by ac- 
tin polymerization, but by other actin-based forces (Be- 
ment et al.,  1993;  Martin and Lewis, 1992; Young et al., 
1993; for review see Cramer et al., 1994). 
We have studied  actin filament dynamics in a  type of 
cell motility called postmitotic cell spreading. During post- 
mitotic cell spreading, cell edges move outward over long, 
thin, actin-rich fibers (retraction fibers, described in Mitch- 
ison  [1992]), which are connected to the  spreading edge 
and the substrate (Cramer and Mitchison, 1993). Our ob- 
servations of the behavior of actin filaments in this system 
could be best explained by the activity of an actin-depen- 
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dent motor. In this study we use inhibition and localization 
experiments to investigate this possibility. We suggest that 
at least one myosin is likely to play a role in postmitotic 
cell spreading. This type of myosin activity may generally 
contribute to forces that drive cell locomotion. 
Materials and Methods 
Handling Butanedione Monoxime 
We store butanedione monoxime (BDM) 1 powder (Sigma Chemical Co., 
St.  Louis, MO) at room temperature in the dark and typically  make a 
fresh 0.5-M stock in water on the day of the experiment, which we keep at 
room temperature for half a  day (it needs vigorous vortexing), but we 
have  occasionally  used a  -20°C 5-M  DMSO stock, both stored in the 
dark. We standardly dilute BDM to 10 mM from the stock concentration 
immediately before an experiment. We have found that BDM is inacti- 
vated by imidazole in aqueous solution. It is stable at 37°C in tissue culture 
media for at least 60 min. 
Purification of Nonmuscle Myosin H and In Vitro 
BDM Studies 
Human platelet nonmuscle myosin II was purified as described (Daniel 
and  Sellers,  1992) except we used a  sephacryl S-400 HR or S-500 HR 
(Sigma Chemical Co.) gel filtration column. ATPase activities  of individ- 
ual,  active,  purified  motor proteins were measured enzymaticaUy  in  a 
spectrophotometer (Catterall and Pederson, 1971) in a final assay volume 
of 80-100  Ixl. 0.1-1 mg/ml platelet myosin II in 0.5 M NaCl or KCI, 10 mM 
MOPS, 20 mM Hepes, pH 7.5, 5 mM MgC12, 0.1 mM EGTA, 1 mM DTr, 
3 mM NAN3, was added to reaction mix (1 mM ATP, 0.5 mM phosphoenol 
pyruvate, 0.25 mM NADH, 0.1%  lactate dehydrogenase, and 0.2%  pyru- 
1. Abbreviations used in this paper: BDM, butanedione monoxime; PtK2, 
Potoroo tridactylis  kidney. 
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muscle actin polymer stabilized with phalloidin (2.5-fold the concentration 
of myosin II).  Active (5.1  ATP/second/dimer after dialysis) chick brain 
myosin V  (gift from Richard Cheney, Yale  University Medical School, 
New Haven, CT), purified as described (Cheney et al., 1993)  was further 
dialyzed in 10 mM Hepes, pH 7.4,  100 mM KC1, 2.5 mM MgC12, 1 mM 
DTT, and 0.1 mM EGTA and immediately assayed at 1-10 txg/ml in 75 
mM KCI, 20 mM Hepes, pH 7.4, 2.5 mM MgC12, 1 mM DTT, 1 mM CaC12 
and reaction mix with 0.5 mg/ml phalloidin-actin. A  Drosophila protein 
fraction  (0.1  mg/ml) with ATPase activity (2.6  txmol/minute/milligram) 
enriched in cytoplasmic myosin and myosin VI and also containing other 
unidentified proteins (proteins eluted with nucleotide from an actin affin- 
ity column as described in Miller et al. [1991], gift from Chris Field, Uni- 
versity of California, San Francisco, CA) was assayed in 50 mM Hepes, 
pH 7.5, 50 mM KC1, 2 mM DTT, 0.5 mM EDTA, 0.5 mM EGTA, 5 mM 
MgCI, and reaction mix with 0.3 mg/ml phalloidin-actin. Active kinesin 
ATPase activity (9.8 ATP/second/dimer) was measured at 7  ~g/ml (hu- 
man partial length recombinant kinesin heavy chain comprising the first 
560 amino acids; Romberg, L., personal communication) in 80 mM Pipes, 
20 mM Hepes, pH 7, 5 mM MgC12, 1 mM EGTA, 25 mM KC1 with reac- 
tion mix and taxol-stabilized 5-mg/ml microtubules (gift from Lisa Bel- 
mont, University of California, San Francisco, CA). Control ATPase ac- 
tivities were monitored for 1-5 min at room temperature and compared 
with that of motor proteins that had been preincubated at room tempera- 
ture with a final concentration of 1-20 mM BDM for 1-5 min. 
Purified skeletal muscle actin monomer was polymerized in F-buffer 
(50 mM Tris, pH 8, 50 mM KCI, 4 mM MgCI2, 1 mM ATP) overnight at 
4°C in the presence of 0-20 mM BDM. The polymer was pelleted and the 
protein concentration measured and compared with total protein. 
Cell Culture 
Potoroo tridactylis kidney (PtK2) cells, an epithelial cell line, were grown, 
plated onto glass coverslips, and transferred into a chamber for time-lapse 
videomicroscopy as described (Cramer and Mitchison, 1993)  except that 
live  cells were  observed at  34-36°C. PtK2 cells were  infected with  L. 
monocytogenes strain 10403S as described (Dabiri et al., 1990) and grown 
and observed as for uninfected cells except that streptomycin and penicil- 
lin were omitted from the media. Both fixed and live postmitotic cells are 
very easily identified. They have a characteristic shape unique to postmi- 
totic cells that is clearly distinct from all other stages of the cell cycle (de- 
scribed in detail in Cramer and Mitchison [1993]). 
Fluorescent Staining of  Actin Filaments and Myosin 
To be able to observe actin filaments and myosin in spreading cells in dou- 
ble label experiments, we developed a method that not only preserved the 
delicate structure of these cells, but was also optimal for observing both 
proteins with phalloidin and the antimyosin antibody, respectively. PtK2 
cells on  glass coverslips were  extracted  in  cytoskeleton buffer  (Small, 
1981;  Symons and  Mitchison, 1991)  with 0.32  M  sucrose, 0.1%  Triton 
X-100, and 1 txg/ml phalloidin (Sigma Chemical Co.) for 45 s. They were 
then fixed in 4% formaldehyde in cytoskeleton buffer with 0.32 M sucrose 
for 20 min, rinsed in TBS (0.15 M NaC1, 0.02 M Tris-C1, pH 7.4), and per- 
meabilized with TBS-0.5% Triton X-100 for 10 min. This method mini- 
mizes loss of free  myosin by only briefly extracting (seconds) and im- 
proves the myosin staining with the antibody in formaldehyde fixed cells 
(methanol is usually used for this antibody, but methanol partially de- 
stroys postmitotic spreading cells, and phalloidin does not bind denatured 
actin filaments). The inclusion of sucrose and phalloidin in the extraction 
buffer and fixing in formaldehyde preserves actin structure, and phalloidin 
also prevents loss of any actin filaments that may have been able to bind 
myosin. Indirect immunofluorescence was performed using affinity-puri- 
fied rabbit anti-human platelet nonmuscle myosin II (Biomedical Tech- 
nologies Inc., Stoughton, MA). Cells were then stained with FITC-conju- 
gated affinipure goat anti-rabbit IgG (H+L) (Jackson ImmunoResearch 
Laboratories, Inc., West Grove, PA) and 0.5-1 ixg/ml rhodamine-phalloi- 
din  (Molecular  Probes,  Inc.,  Eugene,  OR)  and  mounted  on  antifade 
(FITC-guard; Testog Inc., Chicago, IL). 
Cells to be pretreated with BDM were incubated in 10 mM inhibitor 
(concentration known to inhibit cardiac and smooth muscle contraction 
without having other major effects; Blanchard et al., 1990; Spurgeon et al., 
1992; Osterman et al., 1993) in media at 37°C for ~5 min. To observe my- 
osin II, cells were then fixed in -20°C methanol for 1-2.5 min and stained 
as  above,  using rhodamine-conjugated affinipure goat  anti-rabbit  IgG 
(H+L) (Jackson ImmunoResearch Laboratories, Inc.) as a secondary an- 
tibody. To  observe actin filaments, cells were fixed and stained as de- 
scribed (Cramer and Mitchison, 1993). 
Cells were imaged on a photomicroscope (Carl Zeiss, Inc., Thornwood, 
NY) with color reversal (pl600; Eastman Kodak Co., Rochester, NY) or 
hypersensitized Technical Pan film (Alpha Photo Products Inc., Oakland, 
CA). A  red filter was used to minimize any bleedthrough of rhodamine 
fluorescence into the fluorescein channel in double label experiments. In 
immunofluorescence BDM studies (Fig. 2), all photography and printing 
conditions were the same. 
Video Microscopy, In Vivo BDM Studies, 
and Data Collection 
Time-lapse video recording of phase contrast images of live cells and data 
collection were done as described (Cramer and Mitchison, 1993).  A  40x 
Neofluar 0.75 NA objective with a  1 x  eyepiece was used. Cells infected 
with L. monocytogenes were observed 3-4 h  after infection. BDM was 
added directly to cells under observation to final concentrations of 1-20 
mM. BDM was washed out with three to four changes in PBS and then 
two to three changes in media. 
$1 Decoration of  Actin Filaments in Postmitotic 
Spreading Cells 
PtK2  cells were  extracted  (Tilney et  al.,  1992)  in  0.01-0.125%  Triton 
X-100 and 1 p.g/ml phalloidin for 1-5 min, incubated with $1 myosin (gift 
from Kathy Franks, Department of Biochemistry and Biophysics, Univer- 
sity of California, San Francisco, CA)  (Tilney et al., 1992)  for 30 min, 
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Figure 1.  BDM  inhibits the ATPase  activity of nonmuscle myo- 
sin II and myosin V. Human platelet myosin II is inhibited to an 
average 5.1%  (n  =  26) of control ATPase activity after 1-5 min 
preincubation  with  10 mM BDM,  chick brain myosin V  is simi- 
larly inhibited to an average 13.8%  (n  =  13) of control activity, 
and a drosophila  protein fraction enriched in cytoplasmic myosin 
is inhibited  to  an  average  26.6%  (n  =  10)  of control.  Kinesin 
ATPase activity and in vitro assembly of actin is not inhibited by 
10 mM BDM. 
The Journal of Cell Biology, Volume 131, 1995  180 Figure 2.  BDM affects a myosin, but not actin filaments, in PtK2 cells. PtK2 cells were incubated with 10 mM BDM for ~5 min and then 
fixed, permeabilized, and stained for myosin II and actin filaments.  (a) Control cells illustrate  myosin II staining on stress fibers (short 
arrows) and circumferential rings (long arrows). (b) Treated cells have reduced staining on stress fibers (short arrows) and circumferen- 
tial rings (long arrows)  and also stain diffusely in the cytoplasm (arrowheads).  (c and d) Actin filaments are unaffected after 5 min BDM 
treatment (c, arrows) compared with control cells (d, arrows).  Bar, 10 Ixm. 
Results 
BDM Inhibits the ATPase Activity of Nonmuscle 
Myosin H and Myosin V 
To test the possibility that a myosin may play some role in 
postmitotic  PtK2  cell  spreading  we  wished  to  generally 
disrupt the myosins in spreading cells. Progress in under- 
standing the biological roles of other cytoskeletal proteins, 
for example, actin and tubulin, has been helped by the use 
of pharmacological agents. In the absence of known high- 
affinity inhibitors of myosin, we have further characterized 
one potentially useful drug  (BDM)  that  inhibits  contrac- 
tion of intact and permeabilized muscle and septation in a 
fungus with low affinity (Horiuti et al., 1988; Higuchi and 
Takemori,  1989;  Blanchard  et  al.,  1990;  Spurgeon  et  al., 
1992; Yagi et al.,  1992; Osterman  et al.,  1993; Thompson- 
Coffe and Zickler, 1993). In vitro, this drug inhibits skele- 
tal  myosin  II  ATPase  (Higuchi  and  Takemori,  1989). 
From these data it seemed possible that BDM could be a 
general inhibitor of myosins. To test this, we purified non- 
muscle  myosin  II from platelets  essentially  as  described 
(Aldelstein et al., 1971; Daniel and Sellers, 1992). Our pu- 
rified myosin II fraction sometimes contained myosin rod 
domain and actin (as observed in the original platelet my- 
osin II purification;  Aldelstein  et  al.,  1971).  We estimate 
these proteins combined represented  0.5-3%  of the myo- 
sin II protein concentration. Since we wished to study ac- 
tin-activated myosin II ATPase activity and were adding ex- 
cess exogenous actin to any platelet actin, we did not purify 
the myosin II further.  We obtained an average actin-acti- 
vated nonmuscle myosin II ATPase  activity of 6.7  ixmol/ 
minute/milligram as measured spectrophotometrically, which 
is similar to other reports of actin-activated myosin ATPase 
activities.  10  mM  BDM  inhibits  this  ATPase  activity  to 
5.1% of control (Fig. 1). 
We  also  determined  that  10  mM  BDM  inhibits  the 
ATPase  activity of purified  myosin V  (to  13.8%  of con- 
trol) and of a drosophila protein fraction (to 26.6% of con- 
trol) that mostly contains cytoplasmic myosin and myosin 
VI  as  well  as  other  unidentified  actin-binding  proteins. 
BDM does not inhibit  kinesin ATPase activity nor the in 
vitro polymerization of rabbit muscle actin (Fig. 1). 
BDM Affects a Myosin, but Not Actin Filaments, in 
PtK2 Cells 
To confirm that BDM would also affect a myosin, but not 
actin, in PtK2 cells, we treated cells with 10 mM BDM for 
5 min and stained them for nonmuscle myosin II and actin 
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Figure 3.  BDM reversibly inhibits spreading of postmitotic PtK2 cells. Arrowheads in a  and b  indicate the position of the spreading 
edge in a. (a) A  spreading edge before addition of BDM. (b) 980 s later (last 140 s in 10 mM BDM), the edge has spread to the arrows. 
(c) The edge does not spread in the next 760 s of observation in BDM (arrows in c point to the extent of spread in b). (d) BDM is washed 
out and the cell starts spreading again to the short arrows (next 980 s) from its position in c (long arrows). (e) Distance versus time plots 
of three spreading edges before and during BDM (added at the first arrow) and after (from the second arrow) washout (bar). (f) Com- 
parison of the titration curves for inhibition of spreading and platelet nonmuscle myosin II ATPase activity by BDM. Relative rate of 
spreading is the average rate in the presence of BDM as a  percentage of the rate before addition of BDM in the same cell. Relative 
ATPase activity is the average activity in the presence of BDM as a percentage of the activity in the absence of BDM. Bar, 10 ~m. 
The Journal of Cell Biology, Volume 131, 1995  182 filaments. Treated cells have reduced  myosin II staining 
on stress fibers and circumferential rings (compare Fig. 2, 
a  and b). Also, myosin II staining becomes diffuse in the 
cytoplasm in treated cells (Fig. 2 b, arrowheads). We think 
these effects may be a consequence of inactivating myosin 
II ATPase activity, and they are reversible (not shown). 
The BDM-induced disruption of myosin II is not because 
BDM directly disrupts actin filaments; actin filaments are 
not affected after 5 min in BDM (compare Fig. 2, c and d). 
We estimate that, after 5 rain in BDM, >80% of cells have 
reduced  myosin  II stress  fiber  and  circumferential  ring 
staining, whereas actin is affected in only 1% of cells. With 
longer incubations  in BDM, stress fibers get shorter and 
stain less intensely for actin (10%  of cells are affected at 
50-60 min), but this effect on actin considerably lags be- 
hind  that of myosin II (>90%  of cells affected at 50--60 
rain) and is presumably due to general destabilization of 
stress fibers through  loss of myosin. Also,  10 mM BDM 
disrupts cytokinesis in PtK2 cells as expected (cytokinesis 
is either inhibited  or cells do not form normal furrows), 
but  not  microtubules  nor  the  process  of  mitosis  (not 
shown). 
BDM Reversibly Inhibits Spreading of Postmitotic 
PtK2 Cells 
Within 1-3 min after addition of 10 mM BDM to postmi- 
totic  cells,  spreading  edges  stop  moving  forward.  They 
then slightly retract toward the  cell body or remain sta- 
tionary (during 15-30 min of observation in BDM). A typ- 
ical example is shown in Fig. 3. Edges resume spreading 
after washout of BDM at similar rates to before addition 
of inhibitor  (Fig.  3  e).  Cells  spread normally in DMSO, 
which  was used to  dissolve  BDM for some of the  time- 
lapse runs (not shown). The rate of spreading at different 
concentrations of BDM is similar to the extent of inhibi- 
tion  of platelet  nonmuscle  myosin II ATPase  (Fig.  3 f). 
Half maximal inhibition is at 2.5-4 mM BDM. 
It has been reported that 10 mM BDM affects intracel- 
lular calcium in muscle (Horiuti et al., 1988), but our esti- 
mates from data presented in other reports on muscle tis- 
sue show that  10  mM BDM  has little  (Blanchard  et al., 
1990;  Osterman et al., 1993)  or no effect on intracellular 
calcium (Spurgeon et al., 1992).  Inhibition of postmitotic 
cell spreading is unlikely to be due to any affect of BDM 
on intracellular calcium because cells spread normally in 
the  presence  of the  calcium  ionophore  A23187  with  or 
without EGTA in the media (not shown). 
BDM Does Not Inhibit Propulsion of L. monocytogenes 
in PtK2 Cells 
An  alternative  potential  mechanism  for  forward  move- 
ment of cell margins is force from actin polymerization. To 
test whether BDM affects this type of motility, we assayed 
its effect on L. monocytogenes  propulsion, a  type of for- 
ward movement thought to be driven at least in part by ac- 
tin polymerization (Sanger et al., 1992; Theriot and Mitch- 
ison,  1992).  Fig.  4  shows  that  10  mM  BDM  does  not 
significantly change the rate of Listeria propulsion in PtK2 
cells. When the same Listerium  was tracked before and af- 
ter the addition of BDM, no difference in bacterial behav- 
ior was observed. 
Spatial Organization and Polarity of  Actin Filaments in 
Postmitotic Spreading Cells 
We assayed the spatial organization and polarity of actin 
filaments in spreading edges and retraction fibers by deco- 
rating filaments with $1 myosin. Actin filaments in retrac- 
tion  fibers  and  overlapping  actin  polymer  in  spreading 
edges are bundled  and lie perpendicular to the cell edge 
(Fig. 5 a, thin and thick arrows). 90%  of this actin is ori- 
ented with barbed ends towards the distal end of retrac- 
tion fibers (away from the  cell body, in the  direction of 
spreading) (Fig. 5 b, right panel, arrows). Individual retrac- 
tion fiber actin filaments that had their pointed ends facing 
outward (10%) were located randomly within the retrac- 
tion fiber and were not detected to run the length of the fi- 
ber. In contrast, other actin in the spreading edge is more 
randomly oriented and spatially arranged (Fig. 5, a, large 
arrowheads,  short arrows, small arrowheads,  and c, short 
arrows, arrowheads). 
Localization of Myosin H in Mitotic 
and Postmitotic Cells 
To begin to investigate candidate myosins that could have 
a role in postmitotic cell spreading, we fixed and stained 
cells for myosin II and actin filaments. In mitotic cells, cor- 
tical specializations (Mitchison,  1992)  at the retraction fi- 
ber-cell body junction  contain the majority of myosin II 
associated with actin filaments (Fig. 6 b, short arrow, yel- 
low  staining).  Retraction  fibers  contain  actin  filaments 
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Figure 4.  BDM does not inhibit propulsion of L. monocytogenes 
in Ptk2 cells. A selection of typical distance versus time plots of 
the 39 observed Listeria in eight infected  cells before and after 
treatment with 10 mM BDM (added at the arrow; average rate of 
movement in BDM is 107  _+  1% of control Listeria). Each line 
represents a different Listerium tracked during the course of the 
experiment. Any Listeria tracked after 20 min were plotted below 
1,200 s so that a comparison to control Listeria would be mean- 
ingful. 
Cramer and Mitchison  Myosin and Postmitotic Cell Spreading  183 Figure 5.  Spatial orientation and polarity of actin filaments in postmitotic spreading cells. Extracted PtK2 cells were incubated with S1 
myosin, embedded, and sectioned for EM. (a) Actin filaments in retraction fibers are bundled and lie perpendicular (thin, longer ar- 
rows) to the cell margin (doubleheaded arrow) (n =  832/962 filaments =  87% in seven daughters). These or overlapping filaments main- 
The Journal of Cell Biology, Volume 131, t 995  184 Figure 6.  Localization of myosin II in mitotic and  postmitotic cells. PtK2 cells were briefly extracted, fixed, permeabilized, and  co- 
stained for myosin II (green) and actin filaments (red). Myosin II colocalizing with actin filaments appears yellow or yellow-green. (a) 
The antimyosin II antibody we used in b-d recognizes a single major band of 200 kD in PtK2 cell homogenates (~25 txg [lane 1], 50 Ixg 
[lane 2], and 100 txg [lane 3] protein loaded), which comigrates with purified human platelet nonmuscle myosin II ('~0.2 ~g [lane 4], 0.4 
~g [lane 5], and 0.6 Ixg [lane 6] protein loaded) by Western blot. (b) A  rounded-up mitotic cell. Myosin II and actin filaments colocalize 
at the mitotic cell periphery in cortical specializations (short arrow). Retraction fibers contain actin filaments, but do not stain for myo- 
sin II (long arrow) except at the top of some retraction fibers (arrowhead). (c) Spreading edges of postmitotic cells. Myosin II and actin 
filaments colocalize at the spreading edge (arrows). (d) End of spreading. Myosin II is found on stress fibers (long arrow) and on actin 
filaments in the lamella (short arrow), but not in the lamellipodium (between the arrowheads). Bar, l0 Ixm. 
tain this bundled organization across the spreading edge (delineated by three thick, longer arrows behind both retraction fibers). Other 
actin filaments in the spreading edge are more randomly oriented: 325/1,200 filaments =  27% lie perpendicular (large arrowheads), 527/ 
1,200  filaments =  44%  lie parallel (short arrows), and 348/1,200 filaments =  29%  lie oblique (small arrowheads) to the cell margin in 
five daughters. (b) Actin in the retraction fiber and spreading edge bundles is oriented with barbed ends towards the distal end of retrac- 
tion fibers (392/436 filaments =  90% in seven daughters, e.g., right panel, arrows). The right panel is an enlarged version of the area be- 
tween the short arrows in the left panel. An arrowhead denotes the spreading edge and a long arrow the distal end of the retraction fi- 
ber.  (c) 61  and 39%  of actin filaments in spreading edges that  are not in bundles  are oriented with their barbed  (e.g., arrows) and 
pointed (e.g., arrowheads) ends, respectively, toward the spreading margin (n =  385 filaments that have a bias toward the cell edge in 
five daughters). The doubleheaded arrow points to retraction fiber actin. Bar: (a) 145 nm; (b, left panel) 500 nm; (b, right panel) 125 nm; 
(c) 135 nm. 
Cramer and Mitchison Myosin  and Postmitotic Cell Spreading  185 Figure 7.  Detailed distribution of myosin II in postmitotic spreading edges. Paired images of actin (a and c) and myosin 1I (b and d) in 
two spreading edges. Within a spreading edge, myosin II is found on actin filaments that are colinear with actin in retraction fibers (a 
and b, short arrows) and on other actin fibers in the edge (a and b, long arrows), but mostly not detected on retraction fiber actin ahead 
of spreading edges (c and d, arrows) nor on thin regions of actin polymer (a and b, asterisks). Bar, 1.5 ~m. 
b, long arrow).  Myosin II is  also  sometimes  observed  on 
short stretches  of retraction  fibers just below cortical spe- 
cializations  (Fig.  6 b, arrowhead, yellow dots).  In postmi- 
totic  spreading  cells,  the  majority  of myosin  II bound  to 
actin filaments is concentrated  at the spreading edge (Fig. 
6  c,  arrows,  yellow  or  yellow-green  staining).  Myosin  II 
staining is often greater in regions of the cell edge that join 
clusters of retraction fibers (e.g., Fig. 6 c, right arrow) than 
in regions of the cell edge each side of the cluster. This pat- 
tern  correlates  with  faster  spreading  where  retraction  fi- 
bers  are clustered  (Cramer and Mitchison,  1993).  Myosin 
that is not bound to actin is only found in the cell body and 
not in cell edges (e.g., Fig. 6 b, green staining). This is prob- 
ably nonfilamentous because it is readily extracted with in- 
creasing time in detergent (not shown). Toward the end of 
spreading, lamellipodia protrude from the spreading edge, 
The Journal of Cell Biology, Volume 13 l, 1995  186 and  the  postmitotic cell  regains  interphase  morphology. 
Myosin II is found on actin filaments in the lamella (Fig. 6 
d, short arrow) and on stress fibers (Fig. 6 d, long arrow), 
but not in the lamellipodium (Fig. 6 d, between the arrow- 
heads). The localization of myosin II at the edges of post- 
mitotic spreading cells supports the possibility that it could 
play some role in postmitotic cell spreading. Although it is 
beyond the scope of this  article to compare the  distribu- 
tion  of all known myosins in postmitotic spreading cells, 
we found that an antibody to brush border myosin I  (gift 
from Paul Matsudaira, Department of Biology, Massachu- 
setts Institute of Technology, Whitehead Institute for Bio- 
medical  Research,  Cambridge,  MA)  that  recognizes  an 
unknown  myosin  I  isotype  in  PtK2  cells  does  not  stain 
spreading edges (not shown). 
Fig. 7 illustrates the localization of myosin II and actin 
filaments  in  more  detail  in  two  typical  spreading  edges 
fixed in the middle of spreading before lamellipodia pro- 
trusion starts. Within spreading edges, myosin II is readily 
detected on actin filaments, which are colinear with actin 
in retraction fibers (Fig. 7, a  and b, short arrows) and on 
other actin filaments (Fig. 7, a and b, long arrows) in short 
regular stretches  of punctate  staining,  which  may repre- 
sent  individual  myosin II filaments  (Yonemura and  Pol- 
lard, 1992).  Myosin II is not significantly detected on actin 
in retraction fibers themselves (Fig. 7, c and d, arrows). 
Discussion 
Use of BDM as an Inhibitor of Myosin 
Progress on understanding the role of myosins in cell mo- 
tility has been hampered by the absence of pharmacologi- 
cal probes. The best-characterized agent that directly tar- 
gets  myosin  is  BDM.  Several  laboratories  working  on 
muscle contraction  concluded  that  this  agent directly in- 
hibits  actin-myosin  interaction  (Higuchi  and  Takemori, 
1989; Yagi et al., 1992) by inhibiting myosin ATPase activ- 
ity with low affinity (Higuchi and Takemori, 1989).  Some 
reports did not take into account the antagonistic effect of 
imidazole on BDM, and others have suggested additional 
effects of this drug. Calcium levels may be affected in skel- 
etal muscle (e.g., Horiuti et al., 1988), though it is not clear 
if this is a direct effect of the drug, and myosin light chain 
phosphorylation is reduced in smooth muscle (Siegman et 
al., 1994). Calcium levels probably do not directly regulate 
spreading in our system, but we performed additional con- 
trols for the specificity of BDM as an antimyosin agent in 
tissue culture cells.  In vitro, we found that  10 mM BDM 
inhibited nonmuscle myosin II and V ATPase activity, and 
under certain conditions, actin filament motility on muscle 
heavy meromyosin is inhibited to <30% of control, whereas 
kinesin ATPase activity and actin polymerization were un- 
affected (Fig.  1, and Sabry, J., and L. P.  Cramer, unpub- 
lished observations). In vivo, in PtK2 cells we found that 
10 mM BDM disrupts cytokinesis and myosin II localiza- 
tion in stress fibers, but not actin filaments. 10 mM BDM 
also increased the  time between contractions of the  con- 
tractile  vacuole  of  Acanthamoeba  more  than  twofold 
(Cramer, L. P., and T. J. Mitchison, unpublished observa- 
tions),  a  process that  involves the  activity of myosin 1C 
(Doberstein et al., 1993).  In contrast, mitosis and Listeria 
motility in PtK2 cells were unaffected by 10-20 mM BDM, 
arguing against nonspecific effects of BDM on general me- 
tabolism and many ATPases. Taken together, we believe 
that 10 mM BDM is a useful specific inhibitor of some my- 
osins in PtK2 cells. It may be a  general myosin inhibitor, 
though its effects on other myosins, particularly myosin Is, 
still need to be tested. 
A  Role for Myosin in Postmitotic Cell Spreading 
We previously showed that there are two dynamic popula- 
tions of actin filaments in spreading cells differentiated by 
their location and dynamic behavior; one is stationary with 
respect to substrate and is found in retraction fibers and at 
a low level in spreading edges. The other moves forward in 
spreading edges at the same rate as the edge (Cramer and 
Mitchison, 1993).  From this and other data we proposed a 
model in  which  the  activity of a  myosin pulls  actin fila- 
ments in the spreading edge forward as it walks outward 
along retraction  fiber  actin.  In  this  work, we  have  used 
Figure 8.  Actin-dependent forward movement in different types 
of motile systems.  (a)  Forward  movement of the  cell  edge  is 
driven  by the polymerization of actin  monomer (single arrow- 
heads)  into  filaments  (arrowheads)  (e.g.,  lamellipodia  protru- 
sion). (b) Forward movement of the cell edge is driven by acto- 
myosin contraction (e.g., healing of certain kinds of wounds).  (c) 
Forward movement of the cell edge is driven  by myosin (O--O) 
pulling actin  filaments  forward (solid black bar) over other im- 
mobilized  actin  filaments  (arrowheads). Paradoxically,  this  is a 
kind of contraction except the geometry is different  than b, and 
some of the actin does not move (e.g., postmitotic cell spreading). 
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volved in spreading. 
BDM rapidly and reversibly inhibits spreading (Fig. 3). 
Taking into account the caveats discussed above, the sim- 
plest interpretation of these data is  that a  myosin is  in- 
volved in generating the force for spreading.  All known 
myosins that have been tested move toward the barbed- 
end of actin filaments. We find that actin bundles in retrac- 
tion fibers are continuous with bundles of actin filaments 
in the spreading edge, and that 90%  of these  actin fila- 
ments have their barbed ends in the direction of forward 
movement (Fig. 5). This actin (which is stationary, based 
on our previous data) is therefore of the correct polarity to 
support  the  movement  of a  myosin  in  the  direction  of 
spreading.  The  remaining  actin  filaments  in  spreading 
edges have a  more mixed polarity and orientation. This 
less-organized actin accounts for the bulk of actin in the 
spreading edge. Given its more random orientation, it is 
more likely to be transported forward by the myosin. 
Which type of myosin is likely responsible for spread- 
ing? The most abundant myosin in most cells is myosin II. 
We found that myosin II colocalizes with actin filaments in 
spreading edges (Figs. 6 and 7). Also, in fixed cells, myosin 
II appears to move coordinately forward with the spread- 
ing edge because the majority of myosin II is not observed 
on retraction fibers ahead of the edge (Fig. 7). Although 
localization data alone could not distinguish between myo- 
sin II providing force for spreading and simply being a pas- 
senger, we interpret these data in the light of our BDM ex- 
periments.  BDM  acts  rapidly  enough  on  myosin  II  to 
explain inhibition of spreading (Fig. 2), and a role for myo- 
sin II in spreading is consistent with pharmacological data 
that  shows  that the  BDM  titration curves for spreading 
and myosin II ATPase inhibition are very similar (Fig. 3 J0. 
We believe that this drug and localization data taken to- 
gether strengthen our argument that a myosin has a role in 
postmitotic cell spreading. Although we do not rule out the 
possibility that other myosins could also have a role in post- 
mitotic cell spreading, we tested whether myosin II could 
have such a role by treating cells with high affinity inhibitors 
of myosin light  chain kinase  (KT5926 and  kaempferol). 
Nonmuscle myosin II can be regulated by light chain phos- 
phorylation, and certain inhibitors of myosin light chain 
kinase have been used to inactivate this myosin (Lamb et 
al., 1988).  Although we do not yet know the basis for the 
regulation of spreading in PtK2 cells, we found that both 
myosin light chain kinase inhibitors disrupt  the localiza- 
tion of myosin II in PtK2 cells and reduce the rate of post- 
mitotic cell spreading about twofold (Cramer, L. P., and 
T. J. Mitchison, unpublished data). 
Comparison of Postmitotic Cell Spreading to Other 
Types of Cell Motility 
We argue that myosin is involved in postmitotic cell spread- 
ing. In contrast, two other types of cell motility, lamellipo- 
dia protrusion, and Listeria propulsion, are thought to be 
driven at least in part by forces derived from actin poly- 
merization (Wang, 1985; Forscher and Smith, 1988; The- 
riot and Mitchison, 1991, 1992; Sanger et al.,  1992) (Fig. 8 
a). The BDM data are probably the strongest evidence to 
date  that  myosins  are  not required for Listeria motility 
(Fig. 4), although we cannot rule out the possibility that 
other BDM-insensitive motors generate propulsive force. 
De novo lamellipodia protrusion is also not inhibited by 10 
mM  BDM  in  primary  and  tissue  culture  fibrobtasts 
(Cramer, L. P., and T. J. Mitchison, unpublished results). 
Cell spreading is not the only type of edge motility that de- 
pends on myosin. Recently, a type of forward-moving cell 
edge distinct from spreading edges has been observed in 
wound  healing  and  morphogenesis  (Martin  and  Lewis, 
1992; Bement et al.,  1993; Young et al.,  1993). Protrusion 
of this type of edge is probably driven by myosin II (Be- 
ment et al.,  1993; Young et al.,  1993).  However, in these 
systems myosin II may act by its more familiar contractile 
mechanism (Fig. 8 b).  In contrast, the proposed role for 
myosin II in postmitotic cell spreading is more of a trans- 
port motor (Fig. 8 c). 
Forces derived from myosin activity and actin polymer- 
ization are likely to generate forward movement in differ- 
ent types of motile systems (Cramer et al., 1994). With fur- 
ther characterization, BDM may be a  useful reagent for 
distinguishing between these forces, and we are currently 
analyzing the  effects of BDM on a  number of different 
types of motility. In complex motile cell systems, such as 
neuronal growth cones,  and  migrating cells we  envisage 
that motile force is generated from both myosin activity 
and actin polymerization. 
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